Summit Street Capital Management 13F annual report

Summit Street Capital Management is an investment fund managing more than $274 billion ran by Arthur Iii. There are currently 29 companies in Mr. Iii’s portfolio. The largest investments include Berkshire Hathaway and United Therapeutics Corp, together worth $47.1 billion.

$274 billion Assets Under Management (AUM)

As of 7th August 2024, Summit Street Capital Management’s top holding is 58 shares of Berkshire Hathaway currently worth over $35.5 billion and making up 13.0% of the portfolio value. Relative to the number of outstanding shares of Berkshire Hathaway, Summit Street Capital Management owns more than approximately 0.1% of the company. In addition, the fund holds 36,431 shares of United Therapeutics Corp worth $11.6 billion, whose value grew 50.9% in the past six months. The third-largest holding is Lam Research worth $11.6 billion and the next is Applied Matls Inc worth $11.3 billion, with 47,908 shares owned.

Currently, Summit Street Capital Management's portfolio is worth at least $274 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Summit Street Capital Management

The Summit Street Capital Management office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Arthur Iii serves as the Chief Financial Officer at Summit Street Capital Management.

Recent trades

In the most recent 13F filing, Summit Street Capital Management revealed that it had increased its stake in United Therapeutics Corp and bought 2,292 additional shares worth around $740 thousand. This means they effectively own approximately 0.1% of the company. United Therapeutics Corp makes up 40.7% of the fund's Health Care sector allocation and has grown its share price by 38.7% in the past year.

On the other hand, there are companies that Summit Street Capital Management is getting rid of from its portfolio. Summit Street Capital Management closed its position in Gilead Sciences on 14th August 2024. It sold the previously owned 25,064 shares for $1.84 billion. Arthur Iii also disclosed a decreased stake in Applied Matls Inc by approximately 0.1%. This leaves the value of the investment at $11.3 billion and 47,908 shares.

One of the smaller hedge funds

The two most similar investment funds to Summit Street Capital Management are Weil and Paragon Advisors. They manage $274 billion and $274 billion respectively.


Arthur Iii investment strategy

Summit Street Capital Management’s portfolio is diversified across 9 sectors. Currently, their heaviest sector is Technology — making up 17.7% of the total portfolio value. The fund focuses on investments in the United States as 69.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 45% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $58.5 billion.

The complete list of Summit Street Capital Management trades based on 13F SEC filings

These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Berkshire Hathaway Inc.
No change
58
$35,509,978,000 12.97%
United Therapeutics Corp
6.71%
36,431
$11,605,095,000 4.24%
Lam Research Corp.
11.26%
10,889
$11,595,152,000 4.24%
Applied Matls Inc
8.89%
47,908
$11,305,809,000 4.13%
KLA Corp.
11.56%
13,648
$11,252,912,000 4.11%
Micron Technology Inc.
21.78%
82,437
$10,842,939,000 3.96%
Warrior Met Coal Inc
4.61%
171,211
$10,746,914,000 3.93%
Texas Pacific Land Corporati
13.17%
14,419
$10,587,439,000 3.87%
Interdigital Inc
No change
85,585
$9,975,788,000 3.64%
Valero Energy Corp.
1.83%
59,772
$9,369,859,000 3.42%
Consol Energy Inc
12.85%
90,368
$9,220,247,000 3.37%
Elevance Health Inc
6.61%
16,941
$9,179,650,000 3.35%
Marathon Pete Corp
No change
52,644
$9,132,681,000 3.34%
Molina Healthcare Inc
27.14%
28,720
$8,538,456,000 3.12%
HP Inc
10.19%
240,168
$8,410,683,000 3.07%
Humana Inc.
53.52%
22,398
$8,369,013,000 3.06%
Cf Inds Hldgs Inc
18.49%
111,420
$8,258,450,000 3.02%
HF Sinclair Corporation
5.92%
153,606
$8,193,344,000 2.99%
Warner Bros.Discovery Inc
21.98%
1,093,724
$8,137,307,000 2.97%
Kulicke Soffa Inds Inc
21.35%
164,370
$8,085,360,000 2.95%
Cisco Sys Inc
33.10%
168,713
$8,015,555,000 2.93%
Buckle, Inc.
21.43%
216,452
$7,995,737,000 2.92%
Lyondellbasell Industries N
14.04%
81,002
$7,748,651,000 2.83%
Huntsman Corp
20.16%
295,308
$6,724,163,000 2.46%
TriNet Group Inc
No change
63,564
$6,356,400,000 2.32%
Intel Corp.
No change
201,117
$6,228,593,000 2.28%
Gentex Corp.
36.05%
178,028
$6,001,324,000 2.19%
Magna International Inc.
37.95%
99,067
$4,150,907,000 1.52%
Fox Corporation
No change
62,801
$2,158,470,000 0.79%
Gilead Sciences, Inc.
Closed
25,064
$1,835,938,000
Medifast Inc
Closed
29,500
$1,130,440,000
No transactions found
Showing first 500 out of 31 holdings